NT-101

N/A

Report date: 2025/04/09 11:04:08
NME

Base Information

Drug NameNT-101
Drug Alias NameNT-101
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNexThera Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNexThera Co Ltd
Inactive CompaniesN/A
Active IndicationsWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A